# iN Therapeutics: Research, Yongin-si, South Korea

> iN Therapeutics: iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery...

Source: https://millionrounds.com/startup/in-therapeutics (Millionrounds; every figure on the page links to its filing or article)

South Korea · [Research startup](https://millionrounds.com/companies)

# iN Therapeutics

iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for ion channel, Nav1.7 non-opioid an

Email

Funding reported Last round: Series B

Research Yongin-si, South Korea

Follow iN Therapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fin-therapeutics)

Company summary

- **Founded:** 2020 6 years old
- **Team:** 8 1 to 10 people
- **Funding reported:** 40B as listed, currency not stated
- **Last round:** Series B Feb 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for iN Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About iN Therapeutics

iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for ion channel, Nav1.7 non-opioid an

algesic, and the treatments for hearing loss and neurological diseases. iN Therapeutics has the world's best ion channel evaluation platform and development know-how through developing a new drug targeting ion channel which is a promising target of various CNS (Central Nervous System) diseases for about 10 years.

## What company datasets say iN Therapeutics raised

Funding, as reported

Reported in all **40B** in the source's currency

Rounds **2**

Last round **Series B**

Last round size **21.8M**

Last round date **Feb 2022**

Investors listed **10**

## On a portfolio page

Investors who name them

- [Kiwoom Investment](https://millionrounds.com/fund/kiwoom-investment)

Each firm lists iN Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care first-in-class drugs pain management dwp17061 ic50 neurodegenerative diseases kcc2 medical research drug candidates selectivity profile peripheral nervous system neurodegeneration biotech research dwp17061 hospital & health care nav1.7 mechanism of action

Built with from their website

Google Maps Google Tag Manager NAVER Viewport Meta Google Maps Platform Google Font API Mobile Friendly Open Graph jQuery Google Analytics

+7 more

Google Maps (Non Paid Users) Naver Analytics Google Analytics 4 Kakao Nginx jsDelivr Slick

- **Sector:** Research
- **Industry code:** NAICS 541714, 325412, SIC 2834
- **Region:** Gyeonggi-do
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/in-therapeutics)

## Research in South Korea

Startups like it

- [**Galux** founded 2020 *Raised*](https://millionrounds.com/company/galux)
- [**ExoCoBio** founded 2017 *Raised*](https://millionrounds.com/company/exocobio)
- [**Mitoimmune Therapeutics Inc.** Seoul · founded 2018](https://millionrounds.com/startup/mitoimmune-therapeutics-inc)
- [**Cyrus Therapeutics** founded 2019](https://millionrounds.com/startup/cyrus-therapeutics)
- [**G+FLAS Life Sciences, Inc.** Seoul · founded 2014](https://millionrounds.com/startup/g-flas-life-sciences-inc)
- [**Dx & Vx** founded 2001](https://millionrounds.com/startup/dx-vx)
- [**Cellmeat** Seoul · founded 2019](https://millionrounds.com/startup/cellmeat)
- [**Bertis Inc** Seongnam-si · founded 2014](https://millionrounds.com/startup/bertis-inc)

## Is this your company?

Add your raise, your deck and your story, and put iN Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)